Search for an orphan drug
Other search option(s)
Marketing authorization with orphan designation - USA
- Tradename: BOSULIF
- ATC code : -
- EU Number: -
- MA date : 04/09/2012
- MA holder: WYETH PHARMACEUTICALS INC.
Treatment of adult patients with chronic, accelerated or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) with resistance, or intolerance to prior therapy.
The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.